Pharmaceutical Industry Reports Women’s Health Diagnostic Test Market | Page 2

REPORT DESCRIPTION
Women’s Health Diagnostic Test Market – Overview
According to the World Health Organization (WHO), around 570,000 women died due to breast cancer in 2015.
Moreover, according to the Centers for Disease Control and Prevention (CDC), around 236,968 women diagnosed
with breast cancer among which around 41,211 women died in 2014. The data indicating a high prevalence of
chronic diseases affects lifestyle of women day-by-day. Growing demand for early stage diagnosis of
infection/diseases needs new rapid diagnostic tests and imaging system which is expected to fuel the growth of
women’s health diagnostic test market in the near future.
In 2017, Naugatuck Valley Women’s Health Specialists (NVWHS) decided to provide a free informational
program for heart health with Boston Heart Diagnostics. Boston Heart diagnostics has anticipating treatment and
diagnosis of cardiovascular diseases (CVD), which improves women’s heart health, as CVD is a leading disease in
the U.S. This program is expected to create awareness of CVD related diseases among women and also help to
improve lifestyle.
In 2017, Mission Hope Cancer Center accredited by the National Accreditation Program for Breast Cancer
Centers (NAPBC) joined Dignity Health Central Coast hospitals. In Mission Hope’s cancer care program, breast
cancer examination services and facility is expected to be provided to women.